Prøve GULL - Gratis
The prospects for faster growth
Business Standard
|January 13, 2026
While the economy is well poised, key macro numbers and structural constraints continue to weigh
Successive years of rapid economic growth have encouraged commentators to suggest that the economy may at long last be on a higher growth track. This is because growth in the last five financial years (2021-26), taking into account the advance estimates for the current year, averages a handsome 8.1 percent — the best on record.
But this number should be seen in context. The latest five-year record is on the back of a depressed base, because the economy had shrunk in the Covid year, 2020-21. If one takes the pre-Covid year (2019-20) as the base, growth in the latest six years has averaged a less flattering 5.7 per cent. That is slower than the growth record of the previous 19 years, from the turn of the century to the pre-Covid year, a period that averaged 6.5 per cent growth.
‘The key question is how much of the latest growth record represents recovery from the 2020-21 downturn, and what is the sustainable growth rate now. Some published growth forecasts for next year hover around the 6.5 per cent level. On that basis, looking at the three-year cycle (2024-27), growth would average 6.8 percent. That is the same as in the first term of the Modi government. This suggests that there is as yet no marked increase in the sustainable growth rate.
Going beyond the headline growth numbers (which in any case raise questions about data quality), one needs to look at several other numbers to understand the economic situation. For, at most times in earlier periods, one or other economic indicator was often out of kilter. Either inflation was high, or the trade deficit was large, as was the fiscal deficit, or banks and companies had troubled balance sheets. In contrast, the economy today has been characterised as being in a Goldilocks phase, with low inflation, balanced trade, a reduced fiscal deficit, and with bank and corporate balance sheets in their best-ever shape.
Denne historien er fra January 13, 2026-utgaven av Business Standard.
Abonner på Magzter GOLD for å få tilgang til tusenvis av kuraterte premiumhistorier og over 9000 magasiner og aviser.
Allerede abonnent? Logg på
FLERE HISTORIER FRA Business Standard
Business Standard
Labour Codes impact: HCL tech profit slips 11%
Q3 top line beats Street estimates, bottom line misses expectations
2 mins
January 13, 2026
Business Standard
New labour Codes, restructuring weigh on TCS earnings
Tata Consultancy Services (TCS), India’s largest information technology (IT) services firm, saw its profit impacted in the October-December quarter by restructuring and changes in labour Codes.
1 min
January 13, 2026
Business Standard
Black drives the thrill for car buyers
Sees a surge in yearly sales, while white remains practical 'utility king'
2 mins
January 13, 2026
Business Standard
CHOOSING THE RIGHT B-SCHOOL TO MATCH YOUR CAREER GOALS
Success comes when you pick an institution that fits your professional dreams and your personality, helping you become the leader you want to be
2 mins
January 13, 2026
Business Standard
China’s PVC rethink to help India pipe makers
Supply likely to tighten after S-PVC rebate withdrawal
2 mins
January 13, 2026
Business Standard
Responsible growth
India must ensure data centres are sustainable
2 mins
January 13, 2026
Business Standard
India’s GenZ is full of creativity: PM
Prime Minister Narendra Modi on Monday said India's GenZ is full of creativity and with innovative ideas, energy and purpose, the country’s youth is at the forefront of nation-building.
1 min
January 13, 2026
Business Standard
Iran wants to negotiate after threats to attack, says Trump
At least 572 killed in protests; Tehran says situation ‘under full control’
2 mins
January 13, 2026
Business Standard
Insurers knock on Irdai door for clarity on director overlap ban
CLAUSE THREATENS BOARD STRUCTURES AT BANK-BACKED FIRMS SAYS INDUSTRY
2 mins
January 13, 2026
Business Standard
Delhi HC allows Zydus to sell generic version of cancer drug
Citing public interest, the Delhi High Court has cleared the way for Zydus Life-sciences to proceed with the sale of its version of the cancer drug nivolumab in India.
1 min
January 13, 2026
Listen
Translate
Change font size
